(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)dec-9-enoic acid, 97%, 100mg

2-Dimethylamino-5-(trifluoromethyl)pyridine, 98.0%, 5g

L-Cysteine hydrochloride anhydrous, 95.0%, 250g

Oligomycin A, Streptomyces diastatochromogenes., 5mg

2-(5-methyl-1H-indol-3-yl)-2-[3-(trifluoromethyl)phenyl]ethanamine, 50mg

1,2-Dicyano-3,4,5,6-tetrafluorobenzene, 96.0%, 100g

Ethyl 4-chloro-8-methoxyquinoline-3-carboxylate, 95.0%, 5g

6-Methoxy-2-(4-methyl-1,4-diazepan-1-yl)-4-((1-methylpiperidin-4-yl)amino)quinazolin-7-ol (trihydrochloride), 98%, 50mg

2,5-Di-tert-butylphenol, 98%, 250mg

Fusaric acid, min. 99%, 1 g, glass packaging

2-Methyl-5-(piperidin-4-yl)-1,3,4-oxadiazole, 95.0%, 1g

5-Chloro-2,6-dimethylpyrimidin-4-amine, 98+%, 25g

N-(6-Chloro-5-(2-methoxyacetyl)pyridazin-3-yl)pivalamide, 97%, 5g